You are here

relapsing multiple sclerosis

Roche trumpets new fenebrutinib data in relapsing MS

Pharmaphorum

Wed, 09/4/24 - 11:25 am

clinical trials

relapsing multiple sclerosis

Sanofi reports findings from Phase II relapsing MS treatment trial

Clinical Trials Arena

Mon, 07/1/24 - 11:00 am

relapsing multiple sclerosis

clinical trials

Merck KGaA’s BTK Inhibitor Fails Phase III Multiple Sclerosis Studies

BioSpace

Wed, 12/6/23 - 10:44 am

clinical trials

relapsing multiple sclerosis

Roche’s BTK inhibitor succeeds in a Phase II MS trial

Clinical Trials Arena

Wed, 05/17/23 - 10:07 am

clinical trials

relapsing multiple sclerosis

FDA approves Janssen’s PONVORY for treatment of multiple sclerosis

Pharmaceutical Business Review

Mon, 03/22/21 - 10:35 am

relapsing multiple sclerosis

FDA Delays Ruling on Novartis’ Relapsing Multiple Sclerosis Drug

BioSpace

Wed, 06/3/20 - 11:08 am

relapsing multiple sclerosis

Janssen’s MS pill outshines Sanofi’s Aubagio in phase 3 trial

Pharmaforum

Thu, 09/12/19 - 10:28 am

relapsing multiple sclerosis

Novartis’ ofatumumab meets primary endpoints in two phase 3 RMS trials

Pharmaceutical Business Review

Mon, 09/2/19 - 12:24 pm

clinical trials

relapsing multiple sclerosis

Janssen’s Ponesimod Finds Success in Head-to-Head Multiple Sclerosis Trial

BioSpace

Fri, 07/26/19 - 10:59 am

relapsing multiple sclerosis

3 Drugs Under FDA Review With Blockbuster Potential

Motley Fool

Fri, 06/21/19 - 11:24 am

rheumatoid arthritis

wet age-related macular degeneration

relapsing multiple sclerosis

FDA approves Novartis' Mayzent for MS

BioCentury

Tue, 03/26/19 - 11:02 pm

relapsing multiple sclerosis

Roche unveils long-term data from MS blockbuster Ocrevus

Pharmaforum

Wed, 10/10/18 - 10:24 am

relapsing multiple sclerosis

Celgene's Ozanimod Reduces Relapses and Brain Volume Loss in MS Patients in Phase III Trials

CP Wire

Tue, 04/24/18 - 10:31 am

relapsing multiple sclerosis